Literature DB >> 17429039

Disordered lipid metabolism and the pathogenesis of insulin resistance.

David B Savage1, Kitt Falk Petersen, Gerald I Shulman.   

Abstract

Although abnormal glucose metabolism defines type 2 diabetes mellitus (T2DM) and accounts for many of its symptoms and complications, efforts to understand the pathogenesis of T2DM are increasingly focused on disordered lipid metabolism. Here we review recent human studies exploring the mechanistic links between disorders of fatty acid/lipid metabolism and insulin resistance. As "mouse models of insulin resistance" were comprehensively reviewed in Physiological Reviews by Nandi et al. in 2004, we will concentrate on human studies involving the use of isotopes and/or magnetic resonance spectroscopy, occasionally drawing on mouse models which provide additional mechanistic insight.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429039      PMCID: PMC2995548          DOI: 10.1152/physrev.00024.2006

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  131 in total

1.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Authors:  K F Petersen; D Laurent; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

2.  Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653.

Authors:  C Schmitz-Peiffer; N D Oakes; C L Browne; E W Kraegen; T J Biden
Journal:  Am J Physiol       Date:  1997-11

3.  Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.

Authors:  Gina B Di Gregorio; Aiwei Yao-Borengasser; Neda Rasouli; Vijayalakshmi Varma; Tong Lu; Leslie M Miles; Gouri Ranganathan; Charlotte A Peterson; Robert E McGehee; Philip A Kern
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

4.  Early glycogenolysis and late glycogenesis in human liver after intravenous administration of galactose.

Authors:  R Fried; N Beckmann; U Keller; R Ninnis; G Stalder; J Seelig
Journal:  Am J Physiol       Date:  1996-01

5.  Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period.

Authors:  K F Petersen; T Price; G W Cline; D L Rothman; G I Shulman
Journal:  Am J Physiol       Date:  1996-01

6.  In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase.

Authors:  J J Bahl; M Matsuda; R A DeFronzo; R Bressler
Journal:  Biochem Pharmacol       Date:  1997-01-10       Impact factor: 5.858

7.  13C/31P NMR studies on the mechanism of insulin resistance in obesity.

Authors:  K F Petersen; R Hendler; T Price; G Perseghin; D L Rothman; N Held; J M Amatruda; G I Shulman
Journal:  Diabetes       Date:  1998-03       Impact factor: 9.461

8.  Contributions of gluconeogenesis to glucose production in the fasted state.

Authors:  B R Landau; J Wahren; V Chandramouli; W C Schumann; K Ekberg; S C Kalhan
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

9.  Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects.

Authors:  G Perseghin; T B Price; K F Petersen; M Roden; G W Cline; K Gerow; D L Rothman; G I Shulman
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

Review 10.  Mutant insulin receptors in syndromes of insulin resistance.

Authors:  A Krook; S O'Rahilly
Journal:  Baillieres Clin Endocrinol Metab       Date:  1996-01
View more
  370 in total

Review 1.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Trends Biochem Sci       Date:  2010-05-07       Impact factor: 13.807

2.  Palmitic acid acutely stimulates glucose uptake via activation of Akt and ERK1/2 in skeletal muscle cells.

Authors:  Jing Pu; Gong Peng; Linghai Li; Huimin Na; Yanbo Liu; Pingsheng Liu
Journal:  J Lipid Res       Date:  2011-04-25       Impact factor: 5.922

3.  Effect of intensive vs conventional insulin therapy on perioperative nutritional substrates metabolism in patients undergoing gastrectomy.

Authors:  Han-Cheng Liu; Yan-Bing Zhou; Dong Chen; Zhao-Jian Niu; Yang Yu
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 4.  [Obesity: ectopic fat distribution and the heart].

Authors:  Dirk Müller-Wieland; Birgit Knebel; Jutta Haas; Martin Merkel; Jörg Kotzka
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

Review 5.  Metabolic benefits of resistance training and fast glycolytic skeletal muscle.

Authors:  Nathan K LeBrasseur; Kenneth Walsh; Zoltan Arany
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-02       Impact factor: 4.310

6.  Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance.

Authors:  Jieun Lee; Joseph Choi; Ebru S Selen Alpergin; Liang Zhao; Thomas Hartung; Susanna Scafidi; Ryan C Riddle; Michael J Wolfgang
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

7.  Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.

Authors:  Robert A Egnatchik; Alexandra K Leamy; Yasushi Noguchi; Masakazu Shiota; Jamey D Young
Journal:  Metabolism       Date:  2013-10-24       Impact factor: 8.694

8.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

9.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance.

Authors:  Cheol Soo Choi; Jonathan J Fillmore; Jason K Kim; Zhen-Xiang Liu; Sheene Kim; Emily F Collier; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Mario Kahn; Yan Chen; Chunli Yu; Irene K Moore; Richard M Reznick; Takamasa Higashimori; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 10.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.